170 related articles for article (PubMed ID: 3018138)
1. Testing for antibodies to AIDS-associated retrovirus (HTLV-III/LAV) by indirect fixed cell immunofluorescence: specificity, sensitivity, and applications.
Hedenskog M; Dewhurst S; Ludvigsen C; Sinangil F; Rodriguez L; Wu YT; Volsky DJ
J Med Virol; 1986 Aug; 19(4):325-34. PubMed ID: 3018138
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of AIDS-associated retrovirus and antibodies among male homosexuals at risk for AIDS in Greenwich Village.
Casareale D; Dewhurst S; Sonnabend J; Sinangil F; Purtilo DT; Volsky DJ
AIDS Res; 1984-1985; 1(6):407-21. PubMed ID: 6085926
[TBL] [Abstract][Full Text] [Related]
3. Detection of human anti-HTLV-III antibodies by indirect immunofluorescence using fixed cells.
Sandstrom EG; Schooley RT; Ho DD; Byington R; Sarngadharan MG; MacLane ME; Essex M; Gallo RC; Hirsch MS
Transfusion; 1985; 25(4):308-12. PubMed ID: 2992128
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to acquired immune deficiency syndrome (AIDS)-associated virus (HTLV-III/LAV) in Venezuelan populations.
Volsky DJ; Rodriguez L; Dewhurst S; Sinangil F; Sakai K; Merino F; Esparza B; De Salvo L
AIDS Res; 1986; 2(2):79-92. PubMed ID: 3013223
[TBL] [Abstract][Full Text] [Related]
5. Determination of antibodies against LAV/HTLV III: comparative evaluation of four different commercial test kits.
Abb J
AIDS Res; 1986; 2(2):93-7. PubMed ID: 3013224
[TBL] [Abstract][Full Text] [Related]
6. Detection of acquired immunodeficiency syndrome (AIDS) retrovirus antibody by lymphadenopathy-associated virus (LAV) enzyme immunoassay in low- and high-risk populations.
Ragni MV; Lewis JH; Bracken M; Toth R; Stokes J; Steffensen DO
Transfusion; 1986; 26(3):299-301. PubMed ID: 3010516
[TBL] [Abstract][Full Text] [Related]
7. Comparison between enzyme-linked immunosorbent and I.F. assays in the serological diagnosis of HIV infections.
Borghi V; De Palma M; Vecchi M; Pellegrino F; Mongiardo N; Cocchi I; De Rienzo B; Squadrini F
Microbiologica; 1988 Jan; 11(1):81-4. PubMed ID: 3280951
[TBL] [Abstract][Full Text] [Related]
8. Western blot technique in the serological evaluation of three LAV/HTLV III-infected Italian families.
Geroldi D; Aricò M; Plebani A; Maccario R; Notarangelo LD; Duse M; Rey F; Barrè Sinoussi F; Chermann JC; Burgio GR
Infection; 1986; 14(2):60-3. PubMed ID: 3011677
[TBL] [Abstract][Full Text] [Related]
9. Importance of western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood.
Esteban JI; Shih JW; Tai CC; Bodner AJ; Kay JW; Alter HJ
Lancet; 1985 Nov; 2(8464):1083-6. PubMed ID: 2865566
[TBL] [Abstract][Full Text] [Related]
10. Screening and confirmatory tests for antibody to HTLV-III/LAV retrovirus in individuals at risk for AIDS.
De Majo E; Ravina A; Ricciarelli L; Parri F; Mazzetti M; Di Pietro M; Colao MG; Milo D; Romagnani S
Ric Clin Lab; 1986; 16(3):489-94. PubMed ID: 3544160
[TBL] [Abstract][Full Text] [Related]
11. Serological differences between human T-lymphotropic virus type-I (HTLV-I) and HTLV-III/LAV.
Harada S; Purtilo DT; Koyanagi Y; Yamamoto N
Microbiol Immunol; 1986; 30(6):533-44. PubMed ID: 3018457
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to AIDS-associated retrovirus (HTLV-III/LAV) in drug addicts from Vizcaya, northern Spain.
Merino F; Esparza B; Aizpiri J; Fernandez J; de Masdelval L; Arrieta A; Velazquez M; Volsky DJ; San Cristobal E; de Izaguirre A
AIDS Res; 1986; 2(2):133-40. PubMed ID: 3013221
[TBL] [Abstract][Full Text] [Related]
13. LAV/HTLV-III antibodies in patients treated with intravenous gammaglobulins.
Kanoh T; Ohno T; Funakoshi N; Fujii H; Okada T
Tohoku J Exp Med; 1986 Nov; 150(3):361-2. PubMed ID: 2435020
[TBL] [Abstract][Full Text] [Related]
14. Anti-HTLV-III screening of blood donors.
Kühnl P; Seidl S; Holzberger G
Vox Sang; 1986; 51 Suppl 1():15-20. PubMed ID: 3017001
[TBL] [Abstract][Full Text] [Related]
15. Which anti-HTLV III/LAV assays for screening and confirmatory testing?
Mortimer PP; Parry JV; Mortimer JY
Lancet; 1985 Oct; 2(8460):873-7. PubMed ID: 2864587
[TBL] [Abstract][Full Text] [Related]
16. Unique pattern of HTLV-III (AIDS-related) antigen recognition by sera from African children in Uganda (1972).
Saxinger C; Levine PH; Dean A; Lange-Wantzin G; Gallo R
Cancer Res; 1985 Sep; 45(9 Suppl):4624s-4626s. PubMed ID: 2990697
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of HTLV-III/LAV in household contacts of patients with confirmed AIDS and controls in Kinshasa, Zaire.
Mann JM; Quinn TC; Francis H; Nzilambi N; Bosenge N; Bila K; McCormick JB; Ruti K; Asila PK; Curran JW
JAMA; 1986 Aug; 256(6):721-4. PubMed ID: 3014178
[TBL] [Abstract][Full Text] [Related]
18. Detection of antibody to LAV/HTLV-III in sera from hemophiliacs in China.
Zeng Y; Fan J; Zhang Q; Wang PC; Tang DJ; Zhon SC; Zheng XW; Liu DP
AIDS Res; 1986 Dec; 2 Suppl 1():S147-9. PubMed ID: 3103638
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to HTLV-III/LAV among aboriginal Amazonian Indians in Venezuela.
Rodriquez L; Dewhurst S; Sinangil F; Merino F; Godoy G; Volsky DJ
Lancet; 1985 Nov; 2(8464):1098-100. PubMed ID: 2865571
[TBL] [Abstract][Full Text] [Related]
20. HTLV-III/LAV antibodies and virus in hemophilia patients in Nebraska: survey and initiation of a prospective study.
Volsky DJ; Wu YT; Sinangil F; Goldsmith JC
AIDS Res; 1986 Feb; 2(1):51-61. PubMed ID: 2424467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
